Literature DB >> 31611627

Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia.

M Fürstenau1, J Bahlo2, A M Fink2, E Lange3, P Dreger4, M Dreyling5, G Hess6, M Ritgen7, M Kneba7, H Döhner8, S Stilgenbauer8,9, C M Wendtner10, V Goede11, K Fischer2, S Böttcher7,12, M Hallek2,13, B Eichhorst14.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31611627     DOI： 10.1038/s41375-019-0597-3

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

Review 1.  Ibrutinib combinations in CLL therapy: scientific rationale and clinical results.

Authors:  Natalia Timofeeva; Varsha Gandhi
Journal:  Blood Cancer J       Date:  2021-04-29       Impact factor: 11.037

Review 2.  Integrin Signaling Shaping BTK-Inhibitor Resistance.

Authors:  Laura Polcik; Svenja Dannewitz Prosseda; Federico Pozzo; Antonella Zucchetto; Valter Gattei; Tanja Nicole Hartmann
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.